☰

Marcus Laird Forrest, Ph.D. - Publications

Affiliations: 
2003 University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
 2007- Pharmaceutical Chemistry University of Kansas, Lawrence, KS, United States 
Area:
Oncology, Pharmacy, Nanotechnology
Website:
https://pharmacy.ku.edu/people/laird-forrest
Tree Info Similar researchers PubMed Report error

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Chakravarti AR, Groer CE, Gong H, Yudistyra V, Forrest ML, Berkland CJ. Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors. Molecular Pharmaceutics. PMID 36825806 DOI: 10.1021/acs.molpharmaceut.2c00897  0.479
2020 Groer C, Zhang T, Lu R, Cai S, Mull D, Huang A, Forrest M, Berkland CJ, Aires D, Forrest ML. Intratumoral cancer chemotherapy with a carrier-based immunogenic cell death eliciting platinum (IV) agent. Molecular Pharmaceutics. PMID 32975949 DOI: 10.1021/acs.molpharmaceut.0c00781  0.538
2018 Maayah ZH, Zhang T, Forrest ML, Alrushaid S, Doschak MR, Davies NM, El-Kadi AOS. DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways. Pharmaceutics. 10. PMID 30181466 DOI: 10.3390/Pharmaceutics10030144  0.332
2016 Kuehl C, Zhang T, Kaminskas LM, Porter CJ, Davies NM, Forrest ML, Berkland CJ. Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation. Molecular Pharmaceutics. PMID 27157508 DOI: 10.1021/Acs.Molpharmaceut.6B00069  0.516
2015 Thati S, Kuehl C, Hartwell B, Sestak J, Siahaan T, Forrest ML, Berkland C. Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis. Journal of Pharmaceutical Sciences. 104: 714-21. PMID 25447242 DOI: 10.1002/Jps.24272  0.495
2014 Sestak JO, Sullivan BP, Thati S, Northrup L, Hartwell B, Antunez L, Forrest ML, Vines CM, Siahaan TJ, Berkland C. Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis. Molecular Therapy. Methods & Clinical Development. 1: 14008. PMID 26015953 DOI: 10.1038/Mtm.2014.8  0.465
2013 Sestak J, Mullins M, Northrup L, Thati S, Forrest ML, Siahaan TJ, Berkland C. Single-step grafting of aminooxy-peptides to hyaluronan: a simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 334-40. PMID 23541930 DOI: 10.1016/J.Jconrel.2013.03.015  0.478
2012 Duan S, Cai S, Xie Y, Bagby T, Ren S, Forrest ML. Synthesis and characterization of a multi-arm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug. Journal of Polymer Science. Part a, Polymer Chemistry. 50: 2715-2724. PMID 26549934 DOI: 10.1002/Pola.26059  0.787
2012 Remsberg CM, Zhao Y, Takemoto JK, Bertram RM, Davies NM, Forrest ML. Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat. Pharmaceutics. 5: 81-93. PMID 24300398 DOI: 10.3390/Pharmaceutics5010081  0.424
2012 Bagby TR, Duan S, Cai S, Yang Q, Thati S, Berkland C, Aires DJ, Forrest ML. Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 47: 287-94. PMID 22546180 DOI: 10.1016/J.Ejps.2012.04.016  0.78
2012 Shum VW, Gabrielson NP, Forrest ML, Pack DW. The effects of PVP(Fe(III)) catalyst on polymer molecular weight and gene delivery via biodegradable cross-linked polyethylenimine. Pharmaceutical Research. 29: 500-10. PMID 21892707 DOI: 10.1007/S11095-011-0576-5  0.768
2012 Hart DS, Zhao Y, Forrest ML. Polyethylene glycol polyester block copolymers: Biocompatible carriers for nanoparticulate drug delivery Handbook of Harnessing Biomaterials in Nanomedicine. 43-75. DOI: 10.4032/9789814364270  0.322
2012 Cohen S, Mukerji R, Duan S, Cai S, Forrest M, Cohen M. A Novel Nanocarrier Delivery System for Doxorubicin With Improved Tumor Response and Reduced Systemic Toxicity in Advanced Pediatric Non-Hodgkin Lymphoma Journal of Surgical Research. 172: 317. DOI: 10.1016/J.Jss.2011.11.569  0.351
2011 Cohen SM, Mukerji R, Cai S, Damjanov I, Forrest ML, Cohen MS. Evaluation of complete pathologic response and histologic toxicity using a subcutaneous delivery system with combination nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer in vivo. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 279. PMID 27957971 DOI: 10.1200/jco.2011.29.27_suppl.279  0.326
2011 Cai S, Bagby TR, Forrest ML. Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies. Therapeutic Delivery. 2: 1467-84. PMID 22229080 DOI: 10.4155/Tde.11.112  0.776
2011 Cohen SM, Mukerji R, Cai S, Damjanov I, Forrest ML, Cohen MS. Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo. American Journal of Surgery. 202: 646-52; discussion 6. PMID 21982998 DOI: 10.1016/j.amjsurg.2011.06.027  0.3
2011 Cai S, Yang Q, Bagby TR, Forrest ML. Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles. Advanced Drug Delivery Reviews. 63: 901-8. PMID 21712055 DOI: 10.1016/J.Addr.2011.05.017  0.78
2011 Cohen MS, Forrest ML. Lymphatic drug delivery: therapy, imaging and nanotechnology. Preface. Advanced Drug Delivery Reviews. 63: 865-6. PMID 21669240 DOI: 10.1016/j.addr.2011.05.013  0.341
2010 Cai S, Thati S, Bagby TR, Diab HM, Davies NM, Cohen MS, Forrest ML. Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 146: 212-8. PMID 20403395 DOI: 10.1016/J.Jconrel.2010.04.006  0.756
2010 Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International Journal of Pharmaceutics. 392: 156-63. PMID 20363303 DOI: 10.1016/J.Ijpharm.2010.03.058  0.49
2010 Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents. Journal of Pharmaceutical Sciences. 99: 2664-71. PMID 19960530 DOI: 10.1002/Jps.22016  0.34
2010 Rao DA, Forrest ML, Alani AW, Kwon GS, Robinson JR. Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. Journal of Pharmaceutical Sciences. 99: 2018-31. PMID 19902520 DOI: 10.1002/Jps.21970  0.58
2009 Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML, Berkland CJ. Nanoparticles for biomedical imaging. Expert Opinion On Drug Delivery. 6: 1175-94. PMID 19743894 DOI: 10.1517/17425240903229031  0.489
2009 Xie Y, Bagby TR, Cohen MS, Forrest ML. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opinion On Drug Delivery. 6: 785-92. PMID 19563270 DOI: 10.1517/17425240903085128  0.797
2009 Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Advanced Drug Delivery Reviews. 61: 457-66. PMID 19386275 DOI: 10.1016/j.addr.2009.03.010  0.497
2009 Xiong MP, Yáñez JA, Kwon GS, Davies NM, Forrest ML. A cremophor-free formulation for tanespimycin (17-AAG) using PEO-b-PDLLA micelles: characterization and pharmacokinetics in rats. Journal of Pharmaceutical Sciences. 98: 1577-86. PMID 18752263 DOI: 10.1002/Jps.21509  0.752
2008 Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. The Journal of Surgical Research. 147: 247-52. PMID 18498877 DOI: 10.1016/J.Jss.2008.02.048  0.762
2008 Xiong MP, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM, Forrest ML. Formulation of a geldanamycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in rats. Journal of Controlled Release : Official Journal of the Controlled Release Society. 129: 33-40. PMID 18456363 DOI: 10.1016/J.Jconrel.2008.03.015  0.762
2008 Forrest ML, Kwon GS. Clinical developments in drug delivery nanotechnology. Advanced Drug Delivery Reviews. 60: 861-2. PMID 18358557 DOI: 10.1016/J.Addr.2008.02.013  0.571
2008 Forrest ML, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharmaceutical Research. 25: 194-206. PMID 17912488 DOI: 10.1007/S11095-007-9451-9  0.612
2008 Yáñez JA, Forrest ML, Ohgami Y, Kwon GS, Davies NM. Pharmacometrics and delivery of novel nanoformulated PEG-b-poly(epsilon-caprolactone) micelles of rapamycin. Cancer Chemotherapy and Pharmacology. 61: 133-44. PMID 17393166 DOI: 10.1007/S00280-007-0458-Z  0.579
2008 Cohen MS, Cai S, Xie Y, Forrest ML. QS433. Nanocarrier-Conjugated Intralymphatic Chemotherapy: A Novel Approach to Breast Cancer Treatment Journal of Surgical Research. 144: 439. DOI: 10.1016/J.Jss.2007.12.691  0.324
2007 Xiong MP, Forrest ML, Ton G, Zhao A, Davies NM, Kwon GS. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials. 28: 4889-900. PMID 17692910 DOI: 10.1016/J.Biomaterials.2007.07.043  0.743
2007 Xiong MP, Bae Y, Fukushima S, Forrest ML, Nishiyama N, Kataoka K, Kwon GS. pH-responsive Multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery. Chemmedchem. 2: 1321-7. PMID 17579918 DOI: 10.1002/Cmdc.200700093  0.757
2007 Xiong MP, Forrest ML, Karls AL, Kwon GS. Biotin-triggered release of poly(ethylene glycol)-avidin from biotinylated polyethylenimine enhances in vitro gene expression. Bioconjugate Chemistry. 18: 746-53. PMID 17375897 DOI: 10.1021/Bc0602883  0.774
2006 Forrest ML, Zhao A, Won CY, Malick AW, Kwon GS. Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 116: 139-49. PMID 16926059 DOI: 10.1016/J.Jconrel.2006.07.003  0.598
2006 Forrest ML, Won CY, Malick AW, Kwon GS. In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 370-7. PMID 16298448 DOI: 10.1016/J.Jconrel.2005.10.008  0.599
2006 Kwon GS, Forrest ML. Amphiphilic block copolymer micelles for nanoscale drug delivery Drug Development Research. 67: 15-22. DOI: 10.1002/Ddr.20063  0.614
2005 Forrest ML, Gabrielson N, Pack DW. Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. Biotechnology and Bioengineering. 89: 416-23. PMID 15627256 DOI: 10.1002/Bit.20356  0.764
2005 Forrest ML, Pack DW, Kwon GS. Nanocarriers for controlled delivery of therapeutic agents Aiche Annual Meeting, Conference Proceedings. 3344.  0.579
2004 Forrest ML, Meister GE, Koerber JT, Pack DW. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharmaceutical Research. 21: 365-71. PMID 15032320 DOI: 10.1023/B:Pham.0000016251.42392.1E  0.634
2003 Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chemistry. 14: 934-40. PMID 13129396 DOI: 10.1021/Bc034014G  0.637
2002 Forrest ML, Pack DW. On the kinetics of polyplex endocytic trafficking: implications for gene delivery vector design. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 57-66. PMID 12095304 DOI: 10.1006/Mthe.2002.0631  0.611
Show low-probability matches.